ÎçÒ¹¸£Àû1000¼¯ºÏ

medical drugs

A colour-enhanced scanning electron microscope (SEM) image of Magic mushrooms (Psilocybe cubensis). These spores will grow into the fungus that is Psilocybe cubensis , or the magic mushroom. When ingested, this fungus causes euphoria, hallucinations and altered perception of time. Each spore of this strain is approximately 8 by 11 um. Magnification is x660 when printed 10 cm wide.

ÎçÒ¹¸£Àû1000¼¯ºÏ

AI analyses drug users’ trip reports to better understand psychedelics

A pattern recognition algorithm scoured 6850 accounts of people’s experiences with 27 drugs to learn more about how they alter consciousness

News

K4EW53 bearded man in a suit in the city vaping

ÎçÒ¹¸£Àû1000¼¯ºÏ

Vaping probably isn’t a gateway to smoking

News

A coloured scanning electron micrograph of Escherichia coli (E. coli) bacteria on bladder cells in a urine sample from a patient with a urinary tract infection

ÎçÒ¹¸£Àû1000¼¯ºÏ

Recurring UTIs may be prevented with an antiseptic drug

News

Duct tape inspired bandage

Technology

Medical dressing works like duct tape to seal internal wounds

News

Wound dressing

Technology

Electric wound dressing could help injuries heal faster

News

Anadenanthera colubrina is the one tree species common to nearly all regions of South American seasonally dry tropical forests and woodlands (SDTFs). Its abundant fruits each of which is laterally flat and which bear many lenticular seeds, trunk and main stems with a tuberculate cortex, and extra floral nectaries positioned near the base of the leaf rachis distinguish this species.

Humans

Ancient Andean leaders may have mixed hallucinogen with their beer

News

Blood clot, 3d illustration. Inset: Miniature helical robot

Technology

Corkscrew-shaped robot swims through blood vessels to clear blockages

News

Empty bottles in green container; Shutterstock ID 145222138; purchase_order: 08 Jan 2021 issue; job: 08 Jan 2021 - Feature; client: Photo; other:

ÎçÒ¹¸£Àû1000¼¯ºÏ

What the no-alcohol boom means for our drinking habits and health

Features

FILE -- Henry Magendantz, a participant in the Aduhelm clinical trial, finishes receiving an infusion of the drug at Butler Hospital in Providence, R.I., May 27, 2021. Two months before the Food and Drug Administration's deadline to decide whether to approve Biogen's controversial Alzheimer's drug aducanumab, a council of senior agency officials resoundingly agreed that there wasn't enough evidence it worked. (Kayana Szymczak/The New York Times) / Redux / eyevine Please agree fees before use. SPECIAL RATES MAY APPLY. For further information please contact eyevine tel: +44 (0) 20 8709 8709 e-mail: info@eyevine.com www.eyevine.com

ÎçÒ¹¸£Àû1000¼¯ºÏ

2022 preview: Expect a row over controversial Alzheimer's drug

News

Circuit Board With Encoder And Decoder Binary Code Vector Background. Blue Abstract Brain Security Technology Illustration.

ÎçÒ¹¸£Àû1000¼¯ºÏ

Florian Solzbacher interview: Mind-reading implant may soon go on sale

The president of Blackrock Neurotech says the company’s brain-computer interface, designed for people who are paralysed, could be available in 2022 if regulators approve it

News

Technology

AI can quickly identify structure of drugs designed for ‘legal highs’

News

ÎçÒ¹¸£Àû1000¼¯ºÏ

Children born without key immune cells saved with engineered organ

News

ÎçÒ¹¸£Àû1000¼¯ºÏ

Quick saliva test can reveal cannabis use over the past 12 hours

News

ÎçÒ¹¸£Àû1000¼¯ºÏ

The controversial new clinical trials that promise faster results

Features

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop